References
- CRC Crit Rev Biocompat v.2 Bioprostheric heart valve calcification: Chnical features, pathology, and prospects for prevention Levy RJ;Schoen FJ;Golomb G
- J Biomed Mater Res v.22 Biomaterial-associated calcification. Pathology, mechanisms, and strategies for prevention Schoen FJ;Harasaki H;Kim KM(et al.)
- J Biomed Mater Res v.18 Toxic reactions evoked by glutaraldehyde-fixed pericardium and cardiac valve tissue bioprosthesis Gendler E;Gendler S;Nimni ME
- Am J Pathol v.113 Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats Levy RJ;Shoen FJ;Levy JT;Nelson AC;Howard SL;Oshry LJ
- J Thorac Cardiovasc Surg v.89 In vivo hemodynamic comparison of porcine and pericardial valves Cosgrove DM;Lytle BW;Gill CC(et al.)
- Ann Thorac Surg v.46 Inhibition of bioprosthetic heart valve calcification with aminodiphosphonate covalently bound to residual aldehyde groups Webb CL;Benediet JJ;Schoen FJ;Linden JA;Levy RJ
- Biomaterials v.14 Trivalent metal ions in the prevention of calcification in glutaraldehyde treated biological tissues. Is there a chemical correlation? Tan WM;Loke WK;Tan BL;Wee A;Khor E;Goh KS
- J Biomed Mater Res v.27 Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate. Preincubation and controlled release studies Hirsch D;Drader J;Thomas TJ;Schoen FJ;Levy JT;Levy RJ
- Ann Thorac Surg v.64 Refinement of the alpha aminooleic acid bioprosthetic valve anticalcification technique Gott JP;Girardot MN;Girardoi JMD(et al.)
- Med Instrum v.7 Interfacial phenomena and biomaterials Andrade JD
- J Biomed Mater Res v.23 Properties and biological interaction of polyurethane aniomers: Effect of sulfonate incorporation Grasel TG;Cooper SL
- J Biomed Mater Res v.25 Negative cilia concept for thromboresistance Synergistic effect of PEO and sulfonated groups grafted onto polyurethanes Han DK;Jeong SY;Kim YH;Min, BG;Cho HI
-
J Biomed Mater Res
v.27
In vivo biostability and calcification-resistance of surface-modified PU-PEO-
$SO_3$ Han DK;Park KD;Jeong SY(et al.) - ASAIO J v.40 Chemical modification of implantable biologic tissue for anti-calcification Park KD;Yun JY;Han DK(et al.)
- Biomaterials v.18 Novel anti-calcification treatment of biological tissues by grafting of sulfonated poly(ethylene oxide.) Park KD;Lee WK;Yun JY(et al.)
-
대흉외지
v.31
PEO-
$SO_3$ 를 이용한 항성회화 조직첨포의 개발(I)-잡견을 이용한 대동맥과 폐동맥 이식 실험 연구 김형묵;백만종;선경 (등) -
대흉외지
v.31
PEO-
$SO_3$ 를 이용한 항석회화 조직첨포의 개발(III)-동맥과 복막 이식 실험연구- 김형묵;백만종;김광택 (등) - Biomaterials v.17 Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices Jayakrishnan A;Jameela SR
- J Card Surg v.4 Anticalcification treatments of bioprosthetic heart valves: in vivo studies in sheep Jones M;Eidbo EE;Hilbert SL;Ferrans VJ;Clark RE
- J Biomed Mater Res v.22 Heparin immobilization onto segmented polyurethaneurea surfaces-Effect of hydrophilic spacers Park KD;Okano T;Nojiri C;Kim SW
- J Biomed Mater Res v.23 Protein-resistant surfaces prepared by PEO containing block copolymer surfactants Lee JH;Kopecek J;Andrade JD
- Biomaterials v.16 Heparin-like anticoagulant activity of sulphonated poly(ethylene oxide) and sulphonated poly(ethylene oxide) grafted polyurethane Han DK;Lee NY;Park KD;Kim YH;Cho HI;Min BG